BCL2L13 and acute lymphoblastic leukemia: BCL-RAMBO is an independent prognostic factor for ALL (Holleman et al., 2006; Yang et al., 2010) and is associated with a poor clinical outcome for acute myeloid leukemia (Handschuh et al., 2021).